Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investors

Latest news

  • March 1, 2010

    Theratechnologies Announces Publication of Second Phase 3 Results in JAIDS More...

  • February 25, 2010

    Theratechnologies announces a tentative new date for the FDA Advisory Committee review of the tesamorelin New Drug Application More...

Events

  • March 25, 2010

    Annual and Special Meeting of Shareholders, Montréal, Canada

    Thursday, March 25, 2010, at 10:00 a.m.
    Centre Mont-Royal
    2200 Mansfield
    Montréal, Quebec More...

 

Stock information

Symbol TSX : TH
Last trade 4.75
Open 4.85
Net change -0.12
High 4.90
Low 4.75
Volume 59,292
As of 2010-03-19
11:49 EST
Note: Quotes are delayed.
For informational purposes only.